KCT0003698
Not yet recruiting
未知
Safety, effectiveness, and economic evaluation of adjuvant moxibustion therapy for aromataseinhibitor (AI)-induced arthralgia of postmenopausal breast cancer stage ?–? patients: a prospective, randomized, assessor-blind, usual-care controlled, parallel-group, pilot clinical trial
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Kyung Hee University
- Enrollment
- 46
- Status
- Not yet recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Female, aged 45 to 65, who have missed menstrual periods in a row for at least 1 year (amenorrhea) or is showing 45mIU/mL or higher of serum follicle\-stimulating hormone
- •2\) Estrogen receptor positive breast cancer patients of stage I to III, who have completed surgical procedures, chemotherapy, and/or radiation therapy and planned no more active treatments
- •3\) Patients who have been taking the 3rd generation aromatase inhibitors (anastrozole, letrozole, etc.) for 3 months or more and plan to continue the oral administration while participating in this study
- •4\) Patients who are complaining arthralgia in one or more joints, newly developed after the administration of the aromatase inhibitors
- •5\) 4 points or higher of the maximum pain level, assessed with Brief Pain Inventory\-Short Form at screening assessment
- •6\) Volunteers who signed the informed consent forms
Exclusion Criteria
- •1\) Primary/metastatic residual cancer or recurrent cancer
- •2\) History of fracture or surgery in the joints where the pain exists within 3 months
- •3\) History of moxibustion therapy in the joints with aromatase inhibitor\-induced arthralgia within 3 months
- •4\) Present administration of steroid/narcotic analgesics
- •5\) History of allergy to moxibustion or keloid, presence of skin diseases on body parts for moxibustion therapy
- •6\) Refusal to therapy due to moxibustion fear
- •7\) Participation in another clinical study within 1 month
- •8\) Any other inappropriate reasons to participate in the study, judged by the investigators
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Clinical trial for safety, effectiveness, and economic evaluation of Ukgansangajinpibanha in subjects with autism spectrum disorderMental and behavioral disordersKCT0003007Kyung Hee University120
Not yet recruiting
Not Applicable
Effectiveness, safety study of a herbal ointment, Jaungo, for radiation dermatitis of breast cancer patientsNeoplasmsKCT0003506Kyung Hee University80
Not yet recruiting
Not Applicable
Assessment of effectiveness, safety, and cost-effectiveness of an herbal medication (Gongjin-dan) for the patients with chronic dizzinessKCT0002440Kyung Hee University78
Unknown
Not Applicable
The investigation of the safety and efficiency of desk work using automatic wheel chair with assistance for standing in the person with a disability of lower extremityPerson with a disability of lower extremityJPRN-UMIN000023678Tottori University Hospital10
Completed
Not Applicable
Cost effectiveness, safety and efficiency of using a cannulatome versus a cannula for initial cannulation at endoscopic retro-grade cholangiopancreatography (ERCP) in suspected choledocolithiasis.ISRCTN54340540Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)50